ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.035,30
-0,53%
S&P 500
5.116,17
0,32%
Dow Jones
38.386,09
0,38%
Euro vs US Dollar
1,07244
0,08%
Bitcoin
62.021,96
-2,84%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Gilead Sciences Inc (GILD)

  7. Gilead Sciences Inc (GILD) News

GILD Gilead Sciences Inc

65,94
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 11:10:48
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Gilead Sciences Inc GILD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 65,94 11:10:48
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
65,94
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.4.202414:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26.4.202413:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25.4.202422:02BWGilead Sciences Announces First Quarter 2024 Financial..
25.4.202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08.4.202422:05BWGilead Sciences to Release First Quarter 2024 Financial..
28.3.202413:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28.3.202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22.3.202414:18BWGilead Sciences Announces Completion of Acquisition of..
19.3.202400:29BWCenter for Disease Analysis Foundation Announces First Round..
11.3.202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11.3.202413:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06.3.202422:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06.3.202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
06.3.202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05.3.202422:35BWNew Real-World Data Further Support the Use of Veklury®..
05.3.202422:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
01.3.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:49EDGAR2Form 144 - Report of proposed sale of securities
28.2.202422:38EDGAR2Form 144 - Report of proposed sale of securities
27.2.202416:00BWGilead Announces Funding Initiative to Support HIV..
26.2.202422:05BWU.S. FDA Approves Expanded Indication for Gilead’s Biktarvy®..
26.2.202414:30BWGilead to Present Late-Breaking Data and Real-World Evidence..
23.2.202412:09EDGAR2Form SC TO-T - Tender offer statement by Third Party
20.2.202422:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20.2.202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
14.2.202423:08EDGAR2Form SC TO-C - Written communication relating to an issuer..
13.2.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:14EDGAR2Form SC TO-C - Written communication relating to an issuer..
12.2.202414:39EDGAR2Form SC TO-C - Written communication relating to an issuer..
12.2.202414:37EDGAR2Form 8-K - Current report
10.2.202400:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202417:00BWGilead Named One of America’s Most JUST Companies by JUST..
07.2.202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
07.2.202411:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
07.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.2.202422:05BWGilead Sciences Announces 2.7 Percent Increase in First..
06.2.202422:04EDGAR2Form 8-K - Current report
06.2.202422:02BWGilead Sciences Announces Fourth Quarter and Full Year 2023..
06.2.202412:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
02.2.202422:20EDGAR2Form 8-K - Current report
02.2.202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:31BWTed Love, MD, Joins Gilead Sciences’ Board of Directors
31.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten